Valerie Palmieri was appointed Executive Chairwoman of the Board on March 1, 2022. Prior to this Valerie served as President and CEO of Aspira Women's Health from January 2015.
During her tenure at Aspira Women’s Health, Valerie was the architect of the company’s mission, vision and strategy which has led to the company becoming a premier women’s health enterprise. This began with the endorsement of Ova1 by medical society guidelines, payer coverage for the majority of the lives the US, the creation of a second-generation technology, developing an expanded high growth product pipeline known as the “Patient Lifecycle”, and ultimately creating a new corporate brand to serve the company for years to come.
Ova1 has touched over 150,000 patient lives to date. Valerie has over 35 years of experience in the diagnostic laboratory industry, serving in numerous sales, operations, and executive leadership positions for both laboratory service and consulting organizations. Before joining Aspira Women's Health, Palmieri was CEO/President of MOMENTUM Consulting, a national strategicb life science consulting practice. She also served as CEO/President of two healthcare start-ups that resulted in a successful exit for one and won her recognition as one of the “Top 10 US Entrepreneurs of Springboard Enterprises” for the other. She spent six years as National Vice President of Anatomic Pathology Operations with LabCorp, the successor company to DIANON Systems where she served as Senior Vice President of Operations and was a key leader in the sale of DIANON to LabCorp in 2003. Ms. Palmieri holds a Bachelor of Science degree in Medical Technology from Western Connecticut State University.